S&P 500 7,458 -1.55% Nasdaq 25,520 -2.90% Dow Jones 52,146 -0.93% FTSE 100 10,600 +0.98% DAX 24,831 -0.94% Nikkei 225 64,141 -4.61% Hang Seng 25,016 +3.31% WTI Crude 83.89 +5.39% Gold 4,009 -0.87% US 10-Year Treasury Yield 4.541 -1.48% S&P 500 7,458 -1.55% Nasdaq 25,520 -2.90% Dow Jones 52,146 -0.93% FTSE 100 10,600 +0.98% DAX 24,831 -0.94% Nikkei 225 64,141 -4.61% Hang Seng 25,016 +3.31% WTI Crude 83.89 +5.39% Gold 4,009 -0.87% US 10-Year Treasury Yield 4.541 -1.48%

LATEST

SBI Funds Management IPO listing date tomorrow. Here’s what GMP signals about share debut on Dalal Street●Global Market: ASML's AI-fuelled rally raises prospects of becoming Europe's first trillion-dollar company●Ryanair profit slumps 34% as airlines brace for a 'difficult winter' amid Middle East crisis●Multibagger IPO: Recently listed NSE SME stock doubles allottees' money●BHEL share price: Brokerages see up to 23% upside after Maharatna PSU posts first Q1 profit in 8 years●Shares of leading Indian private-sector banks slump 5% on weak earnings in June quarter●CNBC Daily Open: Burnham set to take helm of 'poverty stricken disaster,' says Trump●Big tech earnings to test AI rally as markets enter crucial week●SBI Funds Management IPO listing date tomorrow. Here’s what GMP signals about share debut on Dalal Street●Global Market: ASML's AI-fuelled rally raises prospects of becoming Europe's first trillion-dollar company●Ryanair profit slumps 34% as airlines brace for a 'difficult winter' amid Middle East crisis●Multibagger IPO: Recently listed NSE SME stock doubles allottees' money●BHEL share price: Brokerages see up to 23% upside after Maharatna PSU posts first Q1 profit in 8 years●Shares of leading Indian private-sector banks slump 5% on weak earnings in June quarter●CNBC Daily Open: Burnham set to take helm of 'poverty stricken disaster,' says Trump●Big tech earnings to test AI rally as markets enter crucial week●

Front Page

The market for psychedelic drugs to treat mental health conditions gets a big buy signal

US Top News and Analysis · 16h ago

The market for psychedelic drugs to treat mental health conditions gets a big buy signal

Eli Lilly's acquisition of psychedelic drug maker AtaiBeckley extends Big Pharma's embrace of a stigmatized class of medications for treating mental health.

Read the full story at US Top News and Analysis →

More Front Page

CNBC Daily Open: Burnham set to take helm of 'poverty stricken disaster,' says Trump

US Top News and Analysis · 44m ago

Why can’t Lifestyle & Mobility store show compassion after my loss?

Business | The Guardian · 51m ago

From 'Super El Niño' to Europe’s extreme heatwave: How this year's weather shocks are rattling commodity markets

US Top News and Analysis · 57m ago

FIFA emerges as the $9 billion winner as the biggest, brashest World Cup ever draws to a close

US Top News and Analysis · 1h ago